Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Other Accumulated Expenses for 7 consecutive years, with $649000.0 as the latest value for Q4 2025.

  • Quarterly Other Accumulated Expenses fell 34.38% to $649000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $649000.0 through Dec 2025, down 34.38% year-over-year, with the annual reading at $649000.0 for FY2025, 34.38% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $649000.0 at Precision Biosciences, up from $611000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.8 million in Q1 2024, with the low at $611000.0 in Q3 2025.
  • Average Other Accumulated Expenses over 5 years is $1.4 million, with a median of $1.4 million recorded in 2023.
  • The sharpest move saw Other Accumulated Expenses soared 220.94% in 2023, then tumbled 67.68% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $977000.0 in 2021, then decreased by 23.75% to $745000.0 in 2022, then skyrocketed by 220.94% to $2.4 million in 2023, then crashed by 58.64% to $989000.0 in 2024, then crashed by 34.38% to $649000.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $649000.0, $611000.0, and $721000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.